Microbes: The Environment cleaner

 Microbes: The Environment cleaner

Anthropogenic forces like petroleum spills and the incomplete combustion of fossil fuels, have caused an accumulation of petroleum hydrocarbons in the environment which causes pollution. The accumulation of petroleum and its derivatives now constitutes an important environmental problem. Biocatalysts presents new ways to advance the development of bioremediation approaches. The present-day application of molecular tools to bio catalysis may progress bio prospecting research, enzyme yield recovery, and enzyme specificity. Enzymatic remediation is a valuable alternative as it can be easier to work with than whole organisms, especially in extreme environments. Furthermore, the use of free enzymes avoids the release of exotic or genetically modified organisms (GMO) in the environment.
Numerous microorganisms, such as bacteria, cyanobacteria, green algae, and fungi, are capable of degrading different components of petroleum under different environmental conditions (e.g., aerobic and anaerobic conditions at varied salinities and pHs). The enzymatic apparatus provides these capabilities to microorganisms. Petroleum degradation occurs gradually by sequential metabolism of its compounds. The genes involved in degrading petroleum enzyme production located on chromosomal or plasmid DNA
Their genetic diversity contributes to the metabolic versatility of microorganisms for the conversion of contaminants into less-toxic products, which are then incorporated into natural biogeochemical cycles. The chief benefit of the contaminant-degrading process is the complete mineralisation of compounds, as well as biomass formation which is caused by the microbes.

For more details go through the link : https://bacteriology.infectiousconferences.com/  

Comments

Post a Comment

Popular posts from this blog

Neisseria gonorrhoeae: Combating a Multidrug-Resistant Organism

Image
Neisseria gonorrhoeae: Combating a Multidrug-Resistant Organism: The worldwide spread of anti-toxin resistant sexually transmitted diseases (STD) has received increased consideration in the course of recent years from health institutes including the World Health Organization (WHO) and the Centers for Disease Control and Prevention (CDC). In this post we will give a background marked by multidrug-safe Neisseria gonorrhoeae taken after by a depiction of the test techniques clinical labs are utilizing to decide the antimicrobial susceptibilities of N. gonorrhoeae isolates. About Gonorrhea Gonorrhea is a worldwide widespread disease caused by N. gonorrhoeae, a Gram-negative bacterium. As per CDC, roughly 470,000 new gonorrheal diseases were accounted for. Notwithstanding, on the grounds that numerous cases are asymptomatic, and consequently unreported, it is evaluated that there are roughly 820,000 new cases every year. Furthermore, it is assessed that 246,000 of these cases conv
Read more

The antibiotic that is active against drug-resistant tuberculosis:

Image
The antibiotic that is active against drug-resistant tuberculosis:  A naturally occurring antibiotic called kanglemycin A is effective against Mycobacterium tuberculosis, the bacteria that cause tuberculosis, even in drug-resistant strains, according to an international team of researchers who used chemistry, molecular biology, microbiology, and X-ray crystallography to show how the compound maintains its activity.  The compound, kanglemycin A, is related to the antibiotic rifampicin, according to Katsuhiko Murakami, professor of biochemistry and molecular biology at Penn State and one of leaders of the project. "Rifampicin is already part of the cocktail of antibiotics used to treat tuberculosis, but many strains of the tuberculosis-causing bacteria have developed resistance to it," Murakami said. "Tuberculosis is the leading cause of death by infectious disease worldwide," said Murakami. "Development of rifampicin resistance in M. tuberculosis has m
Read more

A new and promising class of chemical compounds has major potential for treating Zika virus and respiratory syncytial virus, or RSV, according to a new study by University of Alberta scientists. The next step is to develop a drug.

Image
A new and promising class of chemical compounds has major potential for treating Zika virus and respiratory syncytial virus, or RSV, according to a new study by University of Alberta scientists. The next step is to develop a drug... Another and promising class of synthetic mixes has the noteworthy potential for treating Zika disease and respiratory syncytial infection, or RSV, according to another examination by University of Alberta scientists. The accompanying stage is to develop a medication. "This is both a wonderful scientific discovery and something that can possibly emphatically influence worldwide wellbeing as well as the economy of Canada," said Fred West, professor in the Department of Chemistry who led the new discovery along with David Marchant. The compound is alike isatisine A which is an antiviral compound usually found in traditional Chinese herbal medicine. Hobman is a professor of cell biology and a specialist in the Zika virus, a pathogen that can
Read more